Skip to main content
Clinical Trials/NCT00065195
NCT00065195
Completed
Phase 2

Efficacy of Massage at the End of Life

National Center for Complementary and Integrative Health (NCCIH)9 sites in 1 country440 target enrollmentNovember 2003
ConditionsNeoplasmsPain

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Neoplasms
Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Enrollment
440
Locations
9
Primary Endpoint
Decreased pain
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

The purpose of this study is to determine whether massage therapy is effective in reducing pain and distress and improving quality of life among cancer patients at life's end.

Detailed Description

Relieving physical and emotional symptoms is a key component of end-of-life care. Despite care, terminally ill patients are still significantly burdened by unrelieved symptoms. Therapies that have potential to alleviate these symptoms deserve thorough investigation. This study will last 3 weeks. Participants in this study will be randomly assigned to receive six sessions of either moving or nonmoving touch therapy, in addition to usual hospice care, for 2 weeks. Moving touch therapy consists of massage therapy in which a trained therapist continually touches a person's body. The nonmoving touch therapy will be conducted by volunteers who have no previous experience in massage. Participants in this group will have a volunteer rub specific body parts for 3-minute intervals. Because current evidence suggests that thoughts of healing may influence the effectiveness of touch therapy, volunteers in the nonmoving therapy group will distract their minds to avoid thinking of healing processes. In both groups, the person administering the touch therapy will note all interruptions during a session, including talk, music, and television. Interviews about medication use, pain, and quality of life will be used to assess participants; these interviews will be conducted at study start, immediately before and after each therapy session, and at Weeks 1, 2, and 3.

Registry
clinicaltrials.gov
Start Date
November 2003
End Date
March 2007
Last Updated
18 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Advanced cancer, with at least moderate pain 1 week prior to study entry
  • Life expectancy of at least 3 weeks
  • Able to speak English

Exclusion Criteria

  • Massage therapy within 1 month prior to study entry
  • Current use of anticoagulants
  • Platelet count less than 10,000
  • Unstable spine that would interfere with touch therapy

Outcomes

Primary Outcomes

Decreased pain

Secondary Outcomes

  • Less total analgesic medication use.
  • Improved quality of life
  • Decreased physical symptom distress
  • Decreased emotional symptom distress

Study Sites (9)

Loading locations...

Similar Trials